USE OF OLIGOSACCHARIDES CONTAINING N-ACETYLLACTOSAMINE FOR ELICITING IMMUNE RESPONSES IN NEWBORNS Russian patent published in 2013 - IPC A61K31/702 A61K31/715 A23L1/30 A61P37/02 A61P37/04 A61P37/08 

FIELD: medicine, pharmaceutics.

SUBSTANCE: group of inventions refers to medicine, namely to paediatrics and may be used for preparing a drug or therapeutic nutritional composition for maturating an immune responses in a newborn infant. That is ensured by using an oligosaccharide specified in a group consisting of: lacto-N-tetrose, lacto-N-neotetrose, lacto-N-hexose, lacto-N-neohexose, para-lacto-N-hexose, para-lacto-N-neohexose, lacto-N-octose, lacto-N-neooctose, iso-lacto-N-octose, para-lacto-N-octose and lacto-N-decose. Also, the above oligosaccharide may be used for modulating the immune system of the newborn infant to ensure the developing beneficial intestinal microflora for the first weeks of life comparable to such found in breastfed infants.

EFFECT: group of inventions enables the developing beneficial intestinal microflora in the infant, and reduces the risk of a further allergy.

27 cl, 1 ex